AK-7 is primarily utilized in research settings as a selective inhibitor of SIRT2, a member of the sirtuin family of proteins. Its application is significant in studying the role of SIRT2 in various biological processes, including cell cycle regulation, neurodegeneration, and cancer. Researchers use AK-7 to investigate the potential therapeutic effects of SIRT2 inhibition in diseases such as Parkinson's disease, where SIRT2 activity is implicated in the progression of neurodegeneration. Additionally, AK-7 is employed in preclinical studies to explore its impact on cancer cell proliferation and survival, providing insights into novel treatment strategies. Its use as a chemical tool helps elucidate the complex mechanisms of sirtuin-mediated pathways and their implications in health and disease.